Connecticut biotech Veradermics gets $150M for Phase 3 trials of oral Rogainenews2025-10-16T11:30:36+00:00October 16th, 2025|Endpoints News|
Chicago biotech EVOQ pens $500M autoimmune pact with Sanofinews2025-10-16T10:07:32+00:00October 16th, 2025|Endpoints News|
Adcytherix raises €104M Series A to back new ADC drugnews2025-10-16T09:00:55+00:00October 16th, 2025|Endpoints News|
Aicuris’ herpes drug succeeds in Phase 3 study, company saysnews2025-10-16T09:00:40+00:00October 16th, 2025|Endpoints News|
Peter Thiel-backed Peptilogics raises $78M for prosthetic joint infection programnews2025-10-16T09:00:13+00:00October 16th, 2025|Endpoints News|
Ex-FDA leaders take helm of new consultancy, discuss the state of the agencynews2025-10-15T17:45:48+00:00October 15th, 2025|Endpoints News|
BioNTech to get up to €95M in EU funding for a mRNA vaccine site in Africa news2025-10-15T16:07:33+00:00October 15th, 2025|Endpoints News|
Lilly’s oral GLP-1 racks up two more clinical wins in diabetesnews2025-10-15T14:51:43+00:00October 15th, 2025|Endpoints News|
Boehringer makes an ADC deal with AimedBio; EyePoint’s $150M stock salenews2025-10-15T14:38:15+00:00October 15th, 2025|Endpoints News|
Novo Nordisk buys kidney, blood disorder drug from Omerosnews2025-10-15T14:02:15+00:00October 15th, 2025|Endpoints News|
